Cannabinoids have established themselves as therapeutic options in the treatment of pain in recent years. Nevertheless, patients can experience problems when using them, particularly with regard to tolerance. A new aqueous nanodispersion appears to be able to eliminate these problems.
Autoren
- Jens Dehn
Publikation
- InFo RHEUMATOLOGIE
Related Topics
You May Also Like
- Findings from the TRACK-FA study
Neuroimaging biomarkers in Friedreich’s ataxia
- Doing sport without fear or risk
Doing sport without fear or risk
- Chronic inducible urticaria
What has stayed the same, what has changed?
- National Health Report 2025
Mental health in Switzerland
- Blastic plasmacytoid dendritic cell neoplasia
Rare malignancy from a dermatological perspective
- Prevention of skin cancer
UV protection and skin cancer screening – Update 2025
- Paroxysmal nocturnal hemoglobinuria
Real-world data on thrombosis predictors and C5 complement inhibitors
- Glomerulonephritis: IgA nephropathy